Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

RXRX

RECURSION PHARMACEUTICALS, INC.

CIK 0001601830 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$3.50
↑ 0.16 (4.79%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Options; Risks: Fundamentals

Key stats

Market Cap
$1.87B
P/E Ratio
-3.61
EPS
-1.44
Dividend Yield
Not covered
52W Position
17%
Beta
2.85

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
2.05
P/S
34.16
EV/Revenue
24.21
ROE
-56.7%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 17%
$2.77$7.18

Latest Financials

2025-12-31 FY
Revenue
$74.68M
Net Income
-$644.76M
Total Assets
$1.47B
Free Cash Flow
-$378.28M

Recent news